TRCT
TVGN icon

Tower Research Capital (TRC)’s Tevogen Inc TVGN Stock Holding History

Tower Research Capital (TRC)’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.46K Buy
1,494
+553
+59% +$4.42K ﹤0.01% 4070
2026
Q1 		$4.25K Buy
941
+435
+86% +$5.33K ﹤0.01% 4220
2025
Q4 		$8.38K Buy
506
+241
+91% +$6.26K ﹤0.01% 3954
2025
Q3 		$10.4K Sell
265
-58
-18% -$2.85K ﹤0.01% 3982
2025
Q2 		$20.2K Buy
323
+141
+77% +$8.03K ﹤0.01% 3676
2025
Q1 		$9.83K Sell
182
-22
-11% -$1.45K ﹤0.01% 3717
2024
Q4 		$10.5K Buy
204
+14
+7% +$912 ﹤0.01% 3797
2024
Q3 		$3.49K Buy
+190
New +$5.55K ﹤0.01% 4838
2023
Q4 		– Sell
-9
Closed -$4.89K – 6209
2023
Q3 		$4.89K Buy
+9
New +$4.86K ﹤0.01% 4796
2022
Q2 		– Sell
-8
Closed -$4K – 6592
2022
Q1 		$4K Buy
+8
New +$3.98K ﹤0.01% 5269

Other funds holding TVGN

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Tower Research Capital (TRC)'s TVGN Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Tevogen Inc (TVGN) stake by 59% in Q2 2026, buying an estimated $4.42K and bringing the position to 1,494 shares worth $8.46K. The position accounts for ﹤0.01% of the portfolio, ranked #4070.

Tower Research Capital (TRC) first reported a position in TVGN in Q1 2022 and has held it in 10 quarters since. The position peaked at $20.2K in Q2 2025. 30 funds tracked by Wall St. Rank hold TVGN as of Q2 2026.

  • Tower Research Capital (TRC) held 1,494 shares of Tevogen Inc worth $8.46K as of Q2 2026.
  • Tower Research Capital (TRC) bought 553 Tevogen Inc shares in Q2 2026, an estimated $4.42K.
  • Tevogen Inc made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4070 holding.
  • Tower Research Capital (TRC) first reported a position in Tevogen Inc in Q1 2022 and has held it in 10 quarters since.
  • Tower Research Capital (TRC)'s Tevogen Inc position peaked at $20.2K in Q2 2025.
  • 30 funds tracked by Wall St. Rank held Tevogen Inc as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.